Monday, August 3, 2026

Kim Jong Un Hosts Banquet for Russian Delegation, Focusing on Future Cooperation

Kim Jong Un met with a Russian delegation to enhance North Korea-Russia cooperation in trade, economy, and science for mutual prosperity.

NewJeans Breaks Silence: Inside the Drama with HYBE and Min Hee Jin!

K-pop girl group NewJeans stirred controversy by directly addressing their conflict with HYBE and Min Hee Jin, a director at ADOR. 

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.

Celltrion’s Steqeyma IV Approval: What This Means for Celltrion’s Growth in Japan’s Autoimmune Drug Market

Celltrion's Steqeyma IV formulation gains approval in Japan, expanding treatment for Crohn's disease and enhancing market competitiveness.

KRISS Develops Innovative Toxicity Assessment System Using Water Flea Heart Rate Measurement

KRISS has developed an automated system to measure water flea heart rates for precise toxicity assessments, enhancing environmental research.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Revolutionary Long-Lasting Injections: How IVL3003 and IVL3004 are Transforming Dementia and Addiction Treatments

Inventage Lab will present promising results from clinical trials of two long-acting injectables at the 2026 AAN meeting in Chicago.

Coreline Soft’s SaaS Shift: How AI is Transforming Medical Imaging in Europe and Asia

Coreline Soft shifts to a SaaS model, expanding into the European market, enhancing revenue stability, and focusing on policy integration.

Is Your Health at Risk? The Dangerous Rise of Mega Pharmacies in Korea

Mega Factory Pharmacy sells cold medicines without restrictions, raising safety concerns over misuse and impacting neighborhood pharmacies.

BA.3.2 Variant: Is This the New COVID-19 Threat for Asia?

The BA.3.2 COVID-19 variant is spreading globally, prompting health authorities to urge vaccinations for high-risk individuals.

Lunit supplies integrated breast cancer diagnostic solution to Lexington Clinic

Lunit supplies integrated breast cancer AI solutions to Lexington Clinic, enhancing diagnostics and expanding its presence in the Americas.

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

SCL advances digital pathology systems to accelerate precision medicine era

SCL is advancing pathology diagnosis with AI, enhancing accuracy and efficiency in disease detection and personalized treatment.

GC Biopharma Presents Aggregation Study of Alyglo IVIG… A New Benchmark for Safe Immunotherapy

GC Biopharma USA will present findings on IVIG formulations, highlighting Alyglo's lower protein aggregation and improved stability at NHIA 2026.

Fexuclue 40mg: How This New GERD Treatment is Revolutionizing Healthcare in Indonesia

Daewoong Pharmaceutical's Fexuclue receives approval in Indonesia for treating GERD, aiming for rapid expansion in the market.

Discover the Truth of Beauty: How Rejuran is Redefining Skincare in 2026

PharmaResearch launched a video for Rejuran's campaign, emphasizing scientific truth in beauty and consumer trust in skincare.

Top News

- Our Sponsors Ad -

Follow us